Correlation Between Enliven Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Enliven Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Enliven Therapeutics and Entero Therapeutics,
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enliven and Entero is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 4.41 times less return on investment than Entero Therapeutics,. But when comparing it to its historical volatility, Enliven Therapeutics is 4.45 times less risky than Entero Therapeutics,. It trades about 0.07 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 42.00 in Entero Therapeutics, on September 2, 2024 and sell it today you would earn a total of 5.00 from holding Entero Therapeutics, or generate 11.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Entero Therapeutics,
Performance |
| Timeline |
| Enliven Therapeutics |
| Entero Therapeutics, |
Enliven Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Enliven Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |